M Maliepaard

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

S H Kaufmann, C. James, C. Erlichman, 2001, Cancer research.

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.

J. Schellens, W. Dalton, J. Allen, 2000, Cancer research.

Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

J. Schellens, J. Beijnen, J. Schellens, 2000, Journal of the National Cancer Institute.

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

M. J. van de Vijver, J. Schellens, M. Vijver, 2001, Cancer research.

Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.

F H Hausheer, J. Schellens, J. Beijnen, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.